Orthofix Medical (OFIX) Stock Analysis & Winston Score

Orthofix Medical makes medical devices used to fix broken bones and treat spine problems. Its main products include bone growth stimulators, spinal implants, and orthopedic fixation devices — tools that surgeons use to help patients heal after injuries or surgeries. The company sells primarily to hospitals, surgery centers, and spine surgeons across the United States and internationally. Orthofix earns money by selling and renting its devices to healthcare facilities, with bone growth stimulators often reimbursed through insurance. The company operates mainly in the U.S. but has a growing international presence, and its 2023 merger with SeaSpine expanded its spine product portfolio significantly. With a gross margin near 70% but a slightly negative operating margin, Orthofix is still working toward consistent profitability — the key challenge is managing costs and integrating the combined business while competing against much larger rivals like Medtronic and Stryker.